CVS CVS Health Corporation Common Stock
$95,63
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 5, 2026
52W-Spanne
$70–$111
63% of range
Analystenbewertung
BUY
33 analysts
Kursziel
$116
+21% upside
P/E (TTM)
68.8
ROE
2.4%
Nettogewinnmarge
0.44%
Über CVS Health Corporation Common Stock Unternehmensübersicht von Wikipedia
Die CVS Health Corporation ist ein Einzelhandelsunternehmen der Pharmaziebranche in den Vereinigten Staaten. Der Unternehmenssitz befindet sich in Woonsocket, Rhode Island. Das Unternehmen ist im S&P 500 gelistet. CVS betreibt Geschäfte unter dem Namen CVS/pharmacy. CVS steht für Consumer Value Store.
Mehr lesen
Die CVS Health Corporation (oft CVS genannt, vormals CVS Caremark Corporation, davor CVS Corporation) ist ein Einzelhandelsunternehmen der Pharmaziebranche in den Vereinigten Staaten. Der Unternehmenssitz befindet sich in Woonsocket, Rhode Island. Das Unternehmen ist im S&P 500 gelistet. CVS betreibt Geschäfte unter dem Namen CVS/pharmacy. CVS steht für Consumer Value Store.
Mit einem Umsatz von 322,5 Milliarden US-Dollar, bei einem Gewinn von 5,6 Mrd. USD, stand CVS Health im Jahr 2023 laut den Forbes Global 2000 auf Platz 65 der weltgrößten Unternehmen. Laut den Fortune 500 gehörte es 2016 zu den 20 umsatzstärksten Unternehmen weltweit und liegt hier auf Rang 6. Das Unternehmen kam im Juli 2023 auf eine Marktkapitalisierung von 88,92 Mrd. USD.
Im Juni 2023 gab es in den USA 9.572 CVS Pharmacy-Standorte. Der Bundesstaat mit den meisten CVS Pharmacy-Filialen war Kalifornien mit 1.133, also rund 12 % aller Filialen. Neben den Gesundheitsprodukten gibt es in den CVS Läden auch Lebensmittel für den täglichen Bedarf zu kaufen. Die Läden sind jedoch deutlich kleiner als die typischen amerikanischen Supermärkte (z. B. Walmart). Die CVS-Geschäfte ähneln sehr den Walgreens-Läden.
## Unternehmensgeschichte
Das Unternehmen wurde in Lowell, Massachusetts 1963 unter dem Namen Melville Corporation gegründet. 1990 erfolgte eine Fusion mit Peoples Drug aus Washington, D.C. Der Name wurde 1996 in CVS Corporation geändert. 1997 hatte CVS rund 1.400 Geschäfte und übernahm mit dem Konkurrenten Revco weitere 2500 Läden. Durch die Übernahme gelang die Ausweitung des Geschäfts von der Ostküste in den Raum des Südosten der Vereinigten Staaten und in das Gebiet von Ohio. Mit Arbor Drugs aus Michigan erfolgte eine weitere Übernahme und 2004 kaufte CVS 1.260 Filialen der Eckerd Corporation von JCPenney, wodurch eine Expansion in die Regionen Florida und Texas erfolgte. Anfang November 2006 gab CVS die Fusion mit dem Konkurrenten Caremark RX Inc. aus Nashville bekannt. Der Name des Konzerns lautete seitdem CVS Caremark Corporation und ist in allen US-Bundesstaaten vertreten.
Am 5. Februar 2014 kündigte das Unternehmen an, in allen 7600 Filialen bis Oktober 2014 den Verkauf von Zigaretten und anderen Tabakprodukten einzustellen. Das Unternehmen rechnet mit Umsatzeinbußen von rund zwei Milliarden US-Dollar. CEO Larry Merlo begründete diesen Schritt mit den Grundsätzen des Unternehmens. Die Firma wurde in CVS Health umbenannt. Im Dezember 2017 wurde die Übernahme des Versicherers Aetna durch CVS Health für 69 Milliarden US-Dollar bekanntgegeben.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
CVS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$95.63
Marktkapitalisierung
$121.55B
P/E (TTM)
68.8
EPS (TTM)
$1.39
Umsatz (TTM)
$402.07B
Dividendenrendite
2.8%
ROE
2.4%
Verschuldungsgrad
0.0
52W-Spanne
$70 – $111
CVS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$402.07B
2017-12-31
→
2025-12-31
EPS
$1.39
2017-12-31
→
2025-12-31
Freier Cashflow
$7.81B
2017-12-31
→
2025-12-31
Margen
0.44%
2017-12-31
→
2017-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
CVS
Peer-Median
P/E (TTM)
68.8
42.6
P/S (TTM) (K/V (TTM))
0.3
0.3
P/B (K/B)
1.6
0.9
EV / EBITDA
12.0
—
Price / FCF (Kurs / FCF)
15.6
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
CVS
Peer-Median
Operating Margin (Betriebsgewinnmarge)
1.2%
—
Net Profit Margin (Nettogewinnmarge)
0.44%
-7.0%
ROA
0.70%
-10.6%
ROE
2.4%
-20.8%
ROIC
5.0%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
CVS
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.0
8.0
Current Ratio (Liquiditätsgrad)
0.8
1.1
Quick Ratio
0.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
CVS
Peer-Median
Revenue YoY (Umsatz YoY)
7.8%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
7.6%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
8.4%
—
EPS YoY (EPS VjV)
-62.0%
—
Net Income YoY (Nettogewinn YoY)
-61.7%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
CVS
Peer-Median
Payout Ratio (Ausschüttungsquote)
192.1%
—
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
2.8%
Ausschüttungsquote
192.1%
5J Div CAGR
—
| Ex-Datum | Betrag |
|---|---|
| 23. Juli 2026 | $0,6650 |
| 23. April 2026 | $0,6650 |
| 22. Januar 2026 | $0,6650 |
| 23. Oktober 2025 | $0,6650 |
| 22. Juli 2025 | $0,6650 |
| 22. April 2025 | $0,6650 |
| 23. Januar 2025 | $0,6650 |
| 21. Oktober 2024 | $0,6650 |
| 22. Juli 2024 | $0,6650 |
| 19. April 2024 | $0,6650 |
| 19. Januar 2024 | $0,6650 |
| 19. Oktober 2023 | $0,6050 |
| 20. Juli 2023 | $0,6050 |
| 20. April 2023 | $0,6050 |
| 19. Januar 2023 | $0,6050 |
| 20. Oktober 2022 | $0,5500 |
| 21. Juli 2022 | $0,5500 |
| 21. April 2022 | $0,5500 |
| 20. Januar 2022 | $0,5500 |
| 21. Oktober 2021 | $0,5000 |
CVS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
33 Analysten
- Starker Kauf 8 24,2%
- Kauf 20 60,6%
- Halten 5 15,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
25 Analysten · 2026-08-17
Median
$116.00
← Unter allen Zielen
$95.63
Tief
$103.00
Hoch
$148.00
Median-Ziel
$116.00
+21,3%
Mittelwert-Ziel
$116.08
+21,4%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.37%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $2.58 | $1.87 | 0.71% |
| 31. März 2026 | $2.57 | $2.22 | 0.35% |
| 31. Dezember 2025 | $1.09 | $1.00 | 0.09% |
| 30. September 2025 | $1.60 | $1.38 | 0.22% |
| 30. Juni 2025 | $1.81 | $1.47 | 0.34% |
| 31. März 2025 | $2.25 | $1.72 | 0.53% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
| CI | $72.51B | 12.4 | 11.2% | 2.2% | 14.4% | — |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | — |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | — |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| CHE | — | 23.3 | 4.1% | 10.5% | 24.4% | — |
| HIMS | — | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Cost of Revenue | $221.17B | $206.29B | $217.10B | $196.89B | $175.80B | $163.98B | $158.72B | · | $153.45B | $146.53B | $126.76B | |
| Gross Profit | · | · | · | · | · | · | · | · | $28.55B | $28.86B | $26.53B | |
| Operating Expenses | $397.41B | $364.29B | $344.03B | $314.51B | $278.80B | $254.79B | $244.79B | · | $18.81B | $18.45B | $17.05B | |
| Operating Income | $4.66B | $8.52B | $13.74B | $7.95B | $13.31B | $13.91B | $11.99B | · | $9.54B | $10.39B | $9.47B | |
| Interest Expense | · | · | $2.66B | $2.29B | $2.50B | $2.91B | $3.04B | · | $1.06B | $1.08B | $859M | |
| Interest Income | · | · | · | · | · | · | · | · | $21M | $20M | $21M | |
| Other Non-op | $112M | $99M | $88M | $169M | $182M | $206M | $124M | · | $-208M | $-28M | · | |
| Pretax Income | $2.14B | $6.15B | $11.17B | $5.84B | $10.54B | $9.77B | $9.00B | · | $8.27B | $8.64B | $8.62B | |
| Income Tax | $408M | $1.56B | $2.81B | $1.51B | $2.55B | $2.57B | $2.37B | · | $1.64B | $3.32B | $3.39B | |
| Net Income | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| EPS (Basic) | $1.40 | $3.67 | $6.49 | $3.29 | $6.07 | $5.48 | $5.10 | · | $6.47 | $4.93 | $4.66 | |
| EPS (Diluted) | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 | $5.46 | $5.08 | · | $6.44 | $4.90 | $4.63 | |
| Shares (Basic) | 1,267,000,000 | 1,259,000,000 | 1,285,000,000 | 1,312,000,000 | 1,319,000,000 | 1,309,000,000 | 1,301,000,000 | · | 1,020,000,000 | 1,073,000,000 | 1,118,000,000 | |
| Shares (Diluted) | 1,271,000,000 | 1,262,000,000 | 1,290,000,000 | 1,323,000,000 | 1,329,000,000 | 1,314,000,000 | 1,305,000,000 | · | 1,024,000,000 | 1,079,000,000 | 1,126,000,000 | |
| EBITDA | $9.27B | $13.11B | $18.11B | $11.99B | $17.70B | $18.35B | $16.36B | · | $12.00B | $10.34B | $9.45B |
Bilanz 31
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.45B | $8.59B | $8.20B | $12.95B | $9.41B | $7.85B | $5.68B | · | $1.70B | $3.37B | $2.46B | |
| Short-term Investments | $2.15B | $2.41B | $3.26B | $2.78B | $3.12B | $3.00B | $2.37B | · | $111M | $87M | $88M | |
| Receivables | $39.78B | $36.47B | $35.23B | $27.28B | $24.43B | $21.74B | $19.62B | · | $13.18B | $12.16B | $11.89B | |
| Inventory | $19.25B | $18.11B | $18.02B | $19.09B | $17.76B | $18.50B | $17.52B | · | $15.30B | $14.76B | $14.00B | |
| Other Current Assets | $5.09B | $3.08B | $3.15B | $2.64B | $5.29B | $5.28B | $5.11B | $4.53B | $945M | $660M | $722M | |
| Current Assets | $74.71B | $68.64B | $67.86B | $65.63B | $60.01B | $56.37B | $50.30B | $45.20B | $31.23B | $31.04B | $29.16B | |
| PP&E (Net) | · | · | · | $12.87B | $12.90B | $12.61B | $12.04B | $11.36B | $10.29B | $10.18B | $9.86B | |
| PP&E (Gross) | · | · | · | $34.60B | $33.55B | $31.31B | $28.93B | · | $24.29B | $22.80B | $21.04B | |
| Accum. Depreciation | · | · | · | $21.48B | $20.65B | $18.70B | $16.89B | · | $14.00B | $12.63B | $11.18B | |
| Goodwill | $85.48B | $91.27B | $91.27B | $78.15B | $79.12B | $79.55B | $79.75B | · | $38.45B | $38.25B | $38.11B | |
| Intangibles | $25.51B | $27.32B | $29.23B | $24.80B | $29.03B | $31.14B | $33.12B | $36.31B | $13.63B | $13.51B | $13.88B | |
| Other Non-current Assets | $7.11B | $4.79B | $4.66B | $4.62B | $4.71B | $4.62B | $4.60B | $4.53B | $1.42B | $1.49B | $1.44B | |
| Total Assets | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | $216.67B | $95.13B | $94.46B | $92.44B | |
| Accounts Payable | · | · | · | · | · | · | · | · | $8.86B | $7.95B | $7.49B | |
| Accrued Liabilities | $22.39B | $20.81B | $23.52B | $18.75B | $17.67B | $14.24B | $12.13B | $10.66B | $6.58B | $6.94B | $6.83B | |
| Short-term Debt | $0 | $2.12B | $200M | $0 | · | $0 | $0 | · | $1.28B | $1.87B | $0 | |
| Current Liabilities | $88.69B | $84.61B | $79.19B | $69.42B | $67.81B | $62.02B | $53.30B | $45.76B | $30.65B | $26.25B | $23.17B | |
| Capital Leases | $13.64B | $14.90B | $16.03B | $16.80B | $18.18B | $18.76B | $18.93B | $18.83B | $306M | · | · | |
| Deferred Tax | $3.83B | $3.81B | $4.31B | $4.02B | $6.27B | $6.79B | $7.29B | $7.74B | $3.00B | $4.21B | $4.22B | |
| Other Non-current Liabilities | $6.77B | $5.43B | $6.21B | $6.73B | $1.90B | $2.35B | $2.16B | $2.26B | $1.28B | $1.55B | $1.54B | |
| Total Liabilities | $178.16B | $177.49B | $173.09B | $156.51B | $157.62B | $161.01B | $158.28B | $157.95B | $57.44B | · | · | |
| Long-term Debt | · | · | · | · | · | · | $68.48B | $72.61B | $27.00B | $25.70B | $27.50B | |
| Total Debt | $0 | $2.12B | $200M | · | · | · | $3.78B | · | $27.00B | $27.53B | $27.46B | |
| Common Stock | · | $18M | $18M | $18M | $17M | $17M | $17M | · | $17M | $17M | $17M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | $32.08B | $31.62B | $30.95B | |
| Retained Earnings | $61.20B | $62.84B | $61.60B | $56.40B | $54.91B | $49.64B | $45.11B | $41.09B | $43.56B | $38.98B | $35.51B | |
| Treasury Stock | $36.79B | $36.82B | $33.84B | $31.86B | $28.17B | $28.18B | $28.23B | · | $37.80B | $33.45B | $28.89B | |
| AOCI | $406M | $-120M | $-297M | $-1.26B | $965M | $1.41B | $1.02B | · | $-165M | $-305M | $-358M | |
| Stockholders' Equity | $75.21B | $75.56B | $76.46B | $71.47B | $75.08B | $69.39B | $63.86B | $58.40B | $37.69B | $36.83B | $37.20B | |
| Liabilities + Equity | $253.54B | $253.22B | $249.73B | $228.28B | $233.00B | $230.72B | $222.45B | · | $95.13B | $94.46B | $92.44B | |
| Shares Outstanding | 1,271,000,000 | 1,260,000,000 | 1,288,000,000 | 1,300,000,000 | 1,322,000,000 | 1,310,000,000 | 1,302,000,000 | · | 1,712,000,000 | 1,061,000,000 | 1,101,000,000 |
Cashflow 19
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.61B | $4.60B | $4.37B | $4.22B | $4.49B | $4.44B | $4.37B | · | $2.48B | $2.48B | $2.09B | |
| Stock-based Comp | $535M | $540M | $588M | $447M | $484M | $400M | $453M | · | $234M | $222M | $230M | |
| Deferred Tax | $102M | $-572M | $-676M | $-2.03B | $-402M | $-564M | $-649M | · | $-1.42B | $3M | $-234M | |
| Amort. of Intangibles | $2.00B | $2.00B | $1.90B | $1.80B | $2.20B | $2.30B | $2.40B | · | $817M | $795M | $611M | |
| Restructuring | · | · | · | · | · | · | · | · | $215M | · | · | |
| Other Non-cash | $3.63B | $-72M | $804M | $9.41B | $5.79B | $4.41B | $2.04B | · | $93M | · | · | |
| Operating Cash Flow | $10.64B | $9.11B | $13.43B | $16.18B | $18.27B | $15.87B | $12.85B | · | $8.01B | $10.14B | $8.54B | |
| CapEx | $2.83B | $2.78B | $3.03B | $2.73B | $2.52B | $2.44B | $2.46B | · | $1.92B | $2.22B | $2.37B | |
| Investing Cash Flow | $-5.87B | $-7.61B | $-20.89B | $-5.05B | $-5.26B | $-5.53B | $-3.34B | · | $-2.88B | $-2.47B | $-13.42B | |
| Debt Issued | $3.97B | $7.91B | $10.90B | $0 | $987M | $9.96B | $3.74B | · | $0 | $3.46B | $14.80B | |
| Net Debt Issued | $340M | $3.14B | $7.73B | $-4.21B | $-9.27B | $-5.67B | $-4.60B | · | · | $-2.49B | $11.90B | |
| Stock Repurchased | $0 | $3.02B | $2.01B | $3.50B | $0 | $0 | $0 | · | $4.36B | $4.46B | $5.00B | |
| Net Stock Activity | $0 | $-3.02B | $-2.01B | $-3.50B | · | · | $0 | · | $-4.36B | $-4.46B | $-5.00B | |
| Dividends Paid | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B | |
| Financing Cash Flow | $-4.94B | $-1.14B | $2.68B | $-10.52B | $-11.36B | $-7.70B | $-7.65B | · | $-6.75B | $-6.76B | $4.88B | |
| Net Change in Cash | $-172M | $359M | $-4.78B | $614M | $1.65B | $2.63B | $1.85B | · | $-1.62B | $912M | $-22M | |
| Taxes Paid | $2.17B | $1.70B | $3.52B | $4.12B | $3.19B | $2.93B | $2.72B | · | $2.91B | $3.06B | $3.27B | |
| Free Cash Flow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B | $13.43B | $10.39B | · | $6.09B | $7.84B | $6.04B | |
| Levered FCF | · | · | $8.40B | $11.76B | $13.85B | $11.29B | $8.15B | · | $5.24B | $7.18B | $5.52B |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 15.4% | 16.3% | 17.3% | |
| Operating Margin | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% | 5.2% | 4.7% | · | 5.1% | 5.8% | 6.2% | |
| Net Margin | 0.44% | 1.2% | 2.3% | 1.3% | 2.7% | 2.7% | 2.6% | · | 3.6% | 3.0% | 3.4% | |
| Pretax Margin | 0.53% | 1.7% | 3.1% | 1.8% | 3.6% | 3.6% | 3.5% | · | 4.5% | 4.9% | 5.6% | |
| EBITDA Margin | 2.3% | 3.5% | 5.1% | 3.7% | 6.1% | 6.8% | 6.4% | · | 6.5% | 5.8% | 6.2% | |
| ROA | 0.70% | 1.8% | 3.5% | 1.8% | 3.4% | 3.2% | 3.0% | · | 7.0% | 5.7% | 6.2% | |
| ROE | 2.4% | 6.1% | 11.3% | 5.7% | 10.9% | 10.8% | 10.8% | · | 17.8% | 14.4% | 13.9% | |
| ROIC | 5.0% | 8.2% | 13.4% | 8.1% | 13.3% | 14.8% | 13.1% | · | 11.8% | 9.9% | 8.9% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.2 | 1.3 | |
| Quick Ratio | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.6 | 0.6 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | · | · | · | 0.1 | · | 0.7 | 0.7 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | 0.6 | 0.7 | 0.7 | |
| Interest Coverage | · | · | 5.2 | 3.4 | 5.3 | 4.8 | 3.9 | · | 9.0 | 9.6 | 11.0 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.2 | 1.2 | · | 1.9 | 1.9 | 1.8 | |
| Inventory Turnover | 11.8 | 11.4 | 11.7 | 10.7 | 9.7 | 9.1 | 9.3 | · | 10.4 | 10.3 | 9.8 | |
| Receivables Turnover | 10.5 | 10.4 | 11.4 | 12.5 | 12.7 | 13.0 | 13.8 | · | 14.6 | 14.8 | 14.2 |
Wachstumsraten 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.8% | 4.2% | 10.9% | 10.4% | 8.7% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.6% | 8.5% | 10.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -62.0% | -43.4% | 98.5% | -45.9% | 10.3% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -24.7% | -15.3% | 5.8% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -23.9% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -61.7% | -44.7% | 93.5% | -46.1% | 11.5% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -25.7% | -16.8% | 5.1% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -24.4% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B | $268.71B | $256.78B | · | $184.79B | $177.55B | $153.29B | |
| Net Income TTM | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B | $7.18B | $6.63B | · | $6.62B | $5.32B | $5.24B | |
| Market Cap | $100.87B | $56.56B | $101.70B | $121.15B | $136.38B | $89.47B | $96.73B | · | $73.52B | $83.72B | $107.64B | |
| Enterprise Value | $90.27B | $47.69B | $90.45B | · | · | · | $92.45B | · | $98.71B | $107.80B | $132.56B | |
| P/E | 57.1 | 12.3 | 12.2 | 28.6 | 17.1 | 12.5 | 14.6 | · | 11.3 | 16.1 | 21.1 | |
| P/S | 0.3 | 0.2 | 0.3 | 0.4 | 0.5 | 0.3 | 0.4 | · | 0.4 | 0.5 | 0.7 | |
| P/B | 1.3 | 0.7 | 1.3 | 1.7 | 1.8 | 1.3 | 1.5 | · | 2.0 | 2.3 | 2.9 | |
| P / Cash Flow | 9.5 | 6.2 | 7.6 | 7.5 | 7.5 | 5.6 | 7.5 | · | 9.2 | 8.3 | 12.8 | |
| P / FCF | 12.9 | 8.9 | 9.8 | 9.0 | 8.7 | 6.7 | 9.3 | · | 12.1 | 10.7 | 17.8 | |
| EV / EBITDA | 9.7 | 3.6 | 5.0 | · | · | · | 5.7 | · | 8.2 | 10.4 | 14.0 | |
| EV / FCF | 11.6 | 7.5 | 8.7 | · | · | · | 8.9 | · | 16.2 | 13.7 | 21.9 | |
| EV / Revenue | 0.2 | 0.1 | 0.3 | · | · | · | 0.4 | · | 0.5 | 0.6 | 0.9 | |
| Dividend Yield | 3.4% | 6.0% | 3.1% | 2.4% | 1.9% | 2.9% | 2.7% | · | 2.8% | 2.2% | 1.5% | |
| Earnings Yield | 1.8% | 8.2% | 8.2% | 3.5% | 5.8% | 8.0% | 6.8% | · | 8.9% | 6.2% | 4.7% | |
| Payout Ratio | 192.1% | 73.1% | 37.5% | 70.1% | 33.2% | 36.5% | 39.2% | · | 30.9% | 34.6% | 30.1% | |
| Annual Payout | $3.40B | $3.37B | $3.13B | $2.91B | $2.62B | $2.62B | $2.60B | · | $2.05B | $1.84B | $1.58B |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $106.10B | $100.43B | $105.69B | $102.87B | $98.92B | $94.59B | $97.71B | $95.43B | $91.23B | $88.44B | $93.81B | $89.76B | $88.92B | $85.28B | $83.85B | $81.16B | |
| Cost of Revenue | $58.86B | $55.44B | $59.06B | $57.05B | $54.01B | $51.06B | $55.27B | $52.95B | $50.00B | $48.07B | $57.42B | $54.69B | $53.54B | $51.45B | $51.73B | $50.37B | |
| Operating Expenses | $101.39B | $95.75B | $103.58B | $106.08B | $96.53B | $91.21B | $95.34B | $94.60B | $88.19B | $86.17B | $90.44B | $86.07B | $85.69B | $81.83B | $80.19B | $85.08B | |
| Operating Income | $4.70B | $4.68B | $2.11B | $-3.21B | $2.38B | $3.37B | $2.37B | $832M | $3.04B | $2.27B | $3.37B | $3.69B | $3.23B | $3.45B | $3.66B | $-3.92B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $716M | · | $693M | $686M | $589M | · | $566M | |
| Other Non-op | $31M | $32M | $29M | $26M | $29M | $28M | $25M | $25M | $24M | $25M | $22M | $22M | $22M | $22M | $43M | $41M | |
| Pretax Income | $3.98B | $3.94B | $1.35B | $-3.48B | $1.65B | $2.62B | $2.13B | $105M | $2.34B | $1.58B | $2.71B | $3.02B | $2.57B | $2.88B | $3.15B | $-4.44B | |
| Income Tax | $982M | $981M | $-1.57B | $508M | $634M | $835M | $503M | $34M | $569M | $456M | $658M | $754M | $656M | $737M | $818M | $-1.04B | |
| Net Income | $2.98B | $2.94B | $2.94B | $-3.98B | $1.02B | $1.78B | $1.64B | $87M | $1.77B | $1.11B | $2.05B | $2.26B | $1.90B | $2.14B | $2.33B | $-3.41B | |
| EPS (Basic) | $2.33 | $2.31 | $2.31 | $-3.13 | $0.81 | $1.41 | $1.31 | $0.07 | $1.41 | $0.88 | $1.59 | $1.76 | $1.48 | $1.66 | $1.78 | $-2.59 | |
| EPS (Diluted) | $2.31 | $2.30 | $2.31 | $-3.13 | $0.80 | $1.41 | $1.30 | $0.07 | $1.41 | $0.88 | $1.59 | $1.75 | $1.48 | $1.65 | $1.79 | $-2.59 | |
| Shares (Basic) | 1,279,000,000 | 1,273,000,000 | -2,529,000,000 | 1,269,000,000 | 1,266,000,000 | 1,261,000,000 | -2,516,000,000 | 1,259,000,000 | 1,256,000,000 | 1,260,000,000 | -2,568,000,000 | 1,287,000,000 | 1,283,000,000 | 1,283,000,000 | -2,628,000,000 | 1,315,000,000 | |
| Shares (Diluted) | 1,287,000,000 | 1,279,000,000 | -2,532,000,000 | 1,269,000,000 | 1,270,000,000 | 1,264,000,000 | -2,523,000,000 | 1,259,000,000 | 1,259,000,000 | 1,267,000,000 | -2,578,000,000 | 1,290,000,000 | 1,287,000,000 | 1,291,000,000 | -2,641,000,000 | 1,315,000,000 | |
| EBITDA | $5.83B | $5.79B | · | $-2.07B | $3.55B | $4.53B | · | $832M | $3.04B | $3.41B | · | $3.69B | $3.23B | $4.45B | · | $-3.93B |
Bilanz 26
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11.33B | $9.54B | $8.45B | $9.10B | $11.79B | $10.08B | $8.59B | $6.88B | $12.51B | $9.80B | $8.20B | $13.04B | $13.81B | $14.62B | $12.95B | $17.20B | |
| Short-term Investments | $2.63B | $2.26B | $2.15B | $2.13B | $2.39B | $2.58B | $2.41B | $2.81B | $3.75B | $3.29B | · | $3.15B | $3.08B | $3.10B | · | $2.79B | |
| Receivables | $40.31B | $40.99B | $39.78B | $43.86B | $40.65B | $39.62B | $36.47B | $36.18B | $32.38B | $32.22B | · | $32.93B | $29.55B | $28.33B | · | $26.32B | |
| Inventory | $17.62B | $17.77B | $19.25B | $18.96B | $17.45B | $17.39B | $18.11B | $17.65B | $16.07B | $16.35B | · | $17.95B | $17.29B | $18.26B | · | $18.06B | |
| Other Current Assets | $3.46B | $4.25B | $5.09B | $3.06B | $3.38B | $3.53B | $3.08B | $3.83B | $5.24B | $5.82B | · | $3.07B | $3.41B | $3.77B | · | $2.48B | |
| Current Assets | $75.35B | $74.82B | $74.71B | $77.11B | $75.65B | $73.19B | $68.64B | $67.34B | $69.95B | $67.47B | · | $70.14B | $67.76B | $68.71B | · | $68.34B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $13.02B | $13.00B | $12.87B | · | $12.63B | |
| Goodwill | $85.48B | $85.48B | $85.48B | $85.48B | $91.20B | $91.20B | $91.27B | $91.27B | $91.27B | $91.27B | $91.27B | $91.26B | $91.26B | $84.06B | $78.15B | $78.09B | |
| Intangibles | $24.64B | $25.07B | $25.51B | $25.98B | $26.22B | $26.57B | $27.32B | $27.82B | $28.31B | $28.77B | · | $29.62B | $30.12B | $26.37B | · | $25.16B | |
| Other Non-current Assets | $7.43B | $7.42B | $5.12B | $5.16B | $5.21B | $5.23B | $4.79B | $4.76B | $4.80B | $4.80B | · | $4.83B | $4.85B | $4.82B | · | $4.85B | |
| Total Assets | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Accrued Liabilities | $22.48B | $22.26B | $22.39B | $23.41B | $23.10B | $22.37B | $20.81B | $20.17B | $21.16B | $22.35B | · | $22.57B | $22.83B | $21.52B | · | $19.42B | |
| Short-term Debt | · | · | $0 | $1.25B | $3.04B | $1.26B | $2.12B | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Current Liabilities | $87.04B | $86.41B | $88.69B | $92.69B | $94.16B | $88.96B | $84.61B | $84.63B | $81.39B | $83.32B | · | $81.55B | $79.21B | $75.05B | · | $72.41B | |
| Capital Leases | $12.98B | $13.33B | $13.64B | $14.01B | $14.33B | $14.59B | $14.90B | $15.26B | $15.54B | $15.74B | · | $16.44B | $16.61B | $16.57B | · | $17.17B | |
| Deferred Tax | $3.77B | $3.77B | $3.83B | $3.55B | $3.60B | $3.66B | $3.81B | $3.63B | $4.05B | $4.18B | · | $4.25B | $4.59B | $4.09B | · | $3.51B | |
| Other Non-current Liabilities | $6.11B | $6.71B | $4.78B | $4.76B | $4.78B | $5.42B | $5.43B | $5.48B | $5.53B | $6.21B | · | $6.24B | $6.32B | $6.67B | · | $6.77B | |
| Total Liabilities | $173.87B | $175.34B | $178.16B | $182.22B | $180.79B | $178.47B | $177.49B | $177.32B | $177.37B | $175.59B | · | $176.80B | $177.07B | $167.75B | · | $160.20B | |
| Total Debt | · | · | · | $1.25B | $3.04B | $1.26B | · | $800M | $0 | $2.72B | · | · | $1.00B | · | · | · | |
| Common Stock | · | · | · | $18M | $18M | $18M | · | $18M | $18M | $18M | · | $18M | $18M | $18M | $18M | $18M | |
| Retained Earnings | $65.40B | $63.28B | $61.20B | $59.11B | $63.94B | $63.77B | $62.84B | $62.04B | $62.80B | $61.87B | · | $60.34B | $58.87B | $57.75B | · | $54.57B | |
| Treasury Stock | $36.85B | $36.71B | $36.79B | $36.78B | $36.85B | $36.73B | $36.82B | $36.81B | $36.92B | $36.77B | · | $33.83B | $33.93B | $33.80B | · | $30.33B | |
| AOCI | $188M | $201M | $406M | $416M | $272M | $59M | $-120M | $209M | $-319M | $-341M | · | $-1.00B | $-858M | $-875M | · | $-1.61B | |
| Stockholders' Equity | $79.70B | $77.46B | $75.21B | $72.93B | $77.38B | $76.93B | $75.56B | $74.94B | $74.93B | $73.97B | · | $74.34B | $72.73B | $71.38B | · | $70.68B | |
| Liabilities + Equity | $253.77B | $252.97B | $253.54B | $255.33B | $258.34B | $255.59B | $253.22B | $252.43B | $252.48B | $249.74B | · | $251.31B | $250.07B | $239.33B | · | $231.21B | |
| Shares Outstanding | 1,278,000,000 | 1,273,000,000 | 1,271,000,000 | 1,270,000,000 | 1,267,000,000 | 1,262,000,000 | 1,260,000,000 | 1,258,000,000 | 1,256,000,000 | 1,252,000,000 | · | 1,287,000,000 | 1,282,000,000 | 1,279,000,000 | · | 1,315,000,000 |
Cashflow 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.13B | $1.11B | $1.15B | $1.13B | $1.17B | $1.15B | $1.15B | $1.16B | $1.15B | $1.14B | $1.13B | $1.13B | $1.10B | $1.00B | $1.04B | $1.04B | |
| Stock-based Comp | $176M | $266M | $135M | $138M | $136M | $126M | $137M | $133M | $133M | $137M | $127M | $154M | $204M | $103M | $106M | $105M | |
| Amort. of Intangibles | $431M | $442M | $507M | $500M | $494M | $499M | $478M | $507M | $507M | $508M | $504M | $509M | $485M | $402M | $420M | $458M | |
| Other Non-cash | · | $-75M | · | · | · | $1.50B | · | · | · | $2.52B | · | · | · | $4.20B | · | · | |
| Operating Cash Flow | $6.34B | $4.25B | $3.39B | $796M | $1.90B | $4.56B | $1.86B | $-745M | $3.09B | $4.90B | $-2.64B | $2.72B | $5.91B | $7.44B | $-1.95B | $9.12B | |
| CapEx | $691M | $849M | $784M | $698M | $607M | $743M | $768M | $670M | $638M | $705M | $911M | $545M | $591M | $984M | $688M | $580M | |
| Investing Cash Flow | $-1.88B | $-874M | $-2.00B | $-2.09B | $-1.02B | $-762M | $-547M | $-3.35B | $-1.62B | $-2.09B | $-1.24B | $-771M | $-10.36B | $-8.51B | $-119M | $-805M | |
| Debt Issued | · | · | $0 | $3.97B | · | · | $2.95B | $0 | $4.96B | $0 | $0 | $0 | $4.95B | $5.95B | $0 | $0 | |
| Net Debt Issued | · | $-1.52B | · | · | · | $-743M | · | · | · | $-18M | · | · | · | $5.59B | · | · | |
| Stock Repurchased | · | · | $0 | $0 | $0 | $0 | $0 | $-1M | $-3M | $3.03B | $-1M | $-3M | $-2M | $2.02B | $1.50B | $0 | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $-3.03B | · | · | · | $-2.02B | · | · | |
| Dividends Paid | $878M | $847M | $845M | $846M | $866M | $840M | $838M | $837M | $858M | $840M | $779M | $779M | $795M | $779M | $719M | $726M | |
| Financing Cash Flow | $-2.69B | $-2.32B | $-2.03B | $-1.38B | $806M | $-2.33B | $431M | $-1.59B | $1.25B | $-1.23B | $-972M | $-2.70B | $3.63B | $2.73B | $-2.19B | $-3.22B | |
| Net Change in Cash | $1.77B | $1.06B | $-640M | $-2.67B | $1.68B | $1.46B | $1.74B | $-5.68B | $2.71B | $1.58B | $-4.85B | $-752M | $-828M | $1.65B | $-4.26B | $5.10B | |
| Taxes Paid | $374M | $-337M | $998M | $305M | $725M | $138M | $274M | $700M | $666M | $63M | $908M | $837M | $1.70B | $75M | $1.05B | $1.18B | |
| Free Cash Flow | · | $3.40B | · | · | · | $3.81B | · | · | · | $4.20B | · | · | · | $6.45B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $3.69B | · | · | · | $6.02B | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.4% | 4.7% | · | -3.1% | 2.4% | 3.6% | · | 0.87% | 3.3% | 2.6% | · | 4.1% | 3.6% | 4.0% | · | -4.8% | |
| Net Margin | 2.8% | 2.9% | · | -3.9% | 1.0% | 1.9% | · | 0.09% | 1.9% | 1.3% | · | 2.5% | 2.1% | 2.5% | · | -4.2% | |
| Pretax Margin | 3.8% | 3.9% | · | -3.4% | 1.7% | 2.8% | · | 0.11% | 2.6% | 1.8% | · | 3.4% | 2.9% | 3.4% | · | -5.5% | |
| EBITDA Margin | 5.5% | 5.8% | · | -2.0% | 3.6% | 4.8% | · | 0.87% | 3.3% | 3.9% | · | 4.1% | 3.6% | 5.2% | · | -4.8% | |
| ROA | 1.2% | 1.2% | · | -1.6% | 0.40% | 0.70% | · | 0.03% | 0.70% | 0.46% | · | 0.94% | 0.79% | 0.90% | · | -1.5% | |
| ROE | 3.8% | 3.8% | · | -5.4% | 1.3% | 2.4% | · | 0.12% | 2.4% | 1.5% | · | 3.1% | 2.6% | 2.9% | · | -4.7% | |
| ROIC | 4.4% | 4.5% | · | -5.0% | 1.8% | 2.9% | · | 0.74% | 3.1% | 2.1% | · | 3.7% | 3.3% | 3.6% | · | -4.2% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.9 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.9 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | 0.0 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | 5.3 | 4.7 | 5.9 | · | -6.9 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Inventory Turnover | 3.4 | 3.2 | · | 3.1 | 3.2 | 3.0 | · | 3.0 | 3.0 | 2.8 | · | 3.0 | 3.1 | 2.8 | · | 2.8 | |
| Receivables Turnover | 2.6 | 2.5 | · | 2.6 | 2.7 | 2.6 | · | 2.8 | 2.9 | 2.9 | · | 3.0 | 3.1 | 3.1 | · | 3.1 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $408.31B | $396.80B | · | $391.80B | $380.17B | $369.69B | · | $364.86B | $358.36B | $352.40B | · | $345.12B | $335.99B | $323.90B | · | $312.42B | |
| Net Income TTM | $2.97B | $1.77B | · | $-1.09B | $4.66B | $4.75B | · | $5.23B | $7.04B | $7.41B | · | $2.89B | $3.66B | $4.11B | · | $3.58B | |
| Market Cap | $132.21B | $91.43B | · | $95.75B | $87.40B | $85.50B | · | $79.10B | $74.18B | $99.86B | · | $89.86B | $88.62B | $95.04B | · | $125.41B | |
| Enterprise Value | · | · | · | $85.76B | $76.26B | $74.11B | · | $70.22B | $57.92B | $89.49B | · | · | $72.74B | · | · | · | |
| P/E | 45.4 | 52.0 | · | -88.7 | 18.7 | 18.0 | · | 15.3 | 10.7 | 13.8 | · | 30.5 | 24.4 | 23.8 | · | 35.7 | |
| P/S | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.4 | |
| P/B | 1.7 | 1.2 | · | 1.3 | 1.1 | 1.1 | · | 1.1 | 1.0 | 1.4 | · | 1.2 | 1.2 | 1.3 | · | 1.8 | |
| P / Cash Flow | · | 21.5 | · | · | · | 18.8 | · | · | · | 20.4 | · | · | · | 12.8 | · | · | |
| P / FCF | · | 26.9 | · | · | · | 22.4 | · | · | · | 23.8 | · | · | · | 14.7 | · | · | |
| EV / EBITDA | · | · | · | -41.4 | 21.5 | 16.4 | · | 84.4 | 19.0 | 26.3 | · | · | 22.5 | · | · | · | |
| EV / FCF | · | · | · | · | · | 19.4 | · | · | · | 21.3 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.3 | · | · | 0.2 | · | · | · | |
| Earnings Yield | 2.2% | 1.9% | · | -1.1% | 5.3% | 5.6% | · | 6.5% | 9.3% | 7.2% | · | 3.3% | 4.1% | 4.2% | · | 2.8% | |
| Payout Ratio | · | 28.8% | · | · | · | 47.2% | · | · | · | 75.5% | · | · | · | 36.5% | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $402.07B | $372.81B | $357.78B | $322.47B | $292.11B |
| Betriebsgewinnmarge % | 1.2% | 2.3% | 3.8% | 2.4% | 4.5% |
| Nettoergebnis | $1.77B | $4.61B | $8.34B | $4.31B | $8.00B |
| Verwässerte EPS | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.0 | 0.0 | 0.0 | — | — |
| Liquiditätsgrad | 0.8 | 0.8 | 0.9 | 0.9 | 0.9 |
| Quick Ratio | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $7.81B | $6.33B | $10.39B | $13.45B | $15.74B |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- As Americans go direct with GLP-1 prescriptions, Walmart, Costco, Amazon will be big weight-loss winners
- What A Patient Holder Is Really Paying For CVS Health Stock
- Markt-Update: CVS, ETN, KMB, KO, PSX
- Jim Cramer zu CVS: „Ich würde argumentieren, dass es billiger ist“
- Warum der CVS-Aktienkurs am Mittwoch explodierte
- Jim Cramer macht eine bedeutende Aussage über CVS Corporation (CVS)
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 2.290 Einreicher · $77.0B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 319 (+131 vs. Vorquartal) | 93 (-97 vs. Vorquartal) | 783 (+85 vs. Vorquartal) | 714 (-58 vs. Vorquartal) | +184.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $8.618.974.924 | 83.315.369 | 11,20% | Aktien |
| Capital World Investors | $7.753.834.783 | 74.951.955 | 10,08% | Aktien |
| STATE STREET CORP | $6.236.318.558 | 60.283.408 | 8,10% | Aktien |
| Dodge & Cox | $5.173.820.539 | 50.012.765 | 6,72% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $3.266.370.439 | 31.574.388 | 4,24% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.755.624.444 | 26.637.259 | 3,58% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $2.646.473.316 | 25.714.722 | 3,44% | Aktien |
| Capital Research Global Investors | $2.516.851.376 | 24.329.151 | 3,27% | Aktien |
| NORGES BANK | $1.866.126.481 | 18.038.922 | 2,42% | Aktien |
| FMR LLC | $1.684.924.609 | 16.287.333 | 2,19% | Aktien |
| Capital International Investors | $1.591.868.430 | 15.387.600 | 2,07% | Aktien |
| Davis Selected Advisers | $1.227.594.458 | 11.865.916 | 1,60% | Aktien |
| Clearbridge Investments, LLC | $878.119.687 | 8.488.349 | 1,14% | Aktien |
| GQG Partners LLC | $822.989.370 | 7.955.411 | 1,07% | Aktien |
| AMERIPRISE FINANCIAL INC | $761.355.564 | 7.357.966 | 0,99% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $741.242.940 | 7.165.229 | 0,96% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $643.180.166 | 6.217.304 | 0,84% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $524.415.257 | 5.069.263 | 0,68% | Aktien |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $499.125.457 | 4.824.799 | 0,65% | Aktien |
| CITADEL ADVISORS LLC | $493.765.609 | 4.772.988 | 0,64% | Aktien |
| VIKING GLOBAL INVESTORS LP | $378.974.695 | 3.663.361 | 0,49% | Aktien |
| Swiss National Bank | $371.195.152 | 3.588.160 | 0,48% | Aktien |
| BlackRock, Inc. | $364.982.048 | 3.528.101 | 0,47% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $354.997.941 | 3.431.590 | 0,46% | Aktien |
| National Pension Service | $352.166.145 | 3.404.216 | 0,46% | Aktien |
| ROYAL BANK OF CANADA | $338.495.000 | 3.272.060 | 0,44% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $322.653.390 | 3.118.927 | 0,42% | Aktien |
| GOLDMAN SACHS GROUP INC | $319.964.422 | 3.092.938 | 0,42% | Aktien |
| Legal & General Group Plc | $315.302.980 | 3.047.878 | 0,41% | Aktien |
| Holocene Advisors, LP | $310.524.210 | 3.001.684 | 0,40% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $300.309.006 | 2.902.944 | 0,39% | Aktien |
| CITADEL ADVISORS LLC | $299.591.200 | 2.896.000 | 0,39% | Kaufoption |
| Sumitomo Mitsui Trust Group, Inc. | $298.855.050 | 2.888.884 | 0,39% | Aktien |
| Vanguard Global Advisers, LLC | $295.578.375 | 2.857.210 | 0,38% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $295.497.373 | 2.856.427 | 0,38% | Aktien |
| FAIRFAX FINANCIAL HOLDINGS LTD/ CAN | $280.502.160 | 2.712.000 | 0,36% | Aktien |
| CITADEL ADVISORS LLC | $267.076.865 | 2.581.700 | 0,35% | Verkaufsoption |
| BNP PARIBAS FINANCIAL MARKETS | $261.748.880 | 2.530.197 | 0,34% | Aktien |
| BANK OF AMERICA CORP /DE/ | $249.417.276 | 2.410.993 | 0,32% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $246.778.944 | 2.385.490 | 0,32% | Aktien |
| RHUMBLINE ADVISERS | $246.744.475 | 2.385.158 | 0,32% | Aktien |
| FRANKLIN RESOURCES INC | $238.592.528 | 2.306.356 | 0,31% | Aktien |
| California Public Employees Retirement System | $233.879.967 | 2.260.802 | 0,30% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $232.194.060 | 3.233.000 | 0,30% | Aktien |
| JANE STREET GROUP, LLC | $231.055.575 | 2.233.500 | 0,30% | Verkaufsoption |
| CANADA PENSION PLAN INVESTMENT BOARD | $230.615.292 | 2.229.244 | 0,30% | Aktien |
| Canoe Financial LP | $226.952.024 | 2.193.833 | 0,29% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $223.951.974 | 2.164.833 | 0,29% | Aktien |
| VANGUARD GROUP INC | $222.935.255 | 2.809.164 | 0,29% | Aktien |
| UBS Group AG | $221.527.830 | 2.141.400 | 0,29% | Kaufoption |
| Brandywine Global Investment Management, LLC | $216.103.153 | 2.723.074 | 0,28% | Aktien |
| Robeco Institutional Asset Management B.V. | $207.806.227 | 2.008.760 | 0,27% | Aktien |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $205.293.939 | 1.984.475 | 0,27% | Aktien |
| Point72 Asset Management, L.P. | $202.868.760 | 1.961.032 | 0,26% | Aktien |
| JANUS HENDERSON GROUP PLC | $200.732.734 | 2.794.942 | 0,26% | Aktien |
| JANE STREET GROUP, LLC | $190.306.620 | 1.839.600 | 0,25% | Kaufoption |
| JONES FINANCIAL COMPANIES LLLP | $186.577.346 | 1.788.167 | 0,24% | Aktien |
| Assenagon Asset Management S.A. | $183.757.718 | 1.776.295 | 0,24% | Aktien |
| MACKENZIE FINANCIAL CORP | $177.786.480 | 1.718.574 | 0,23% | Aktien |
| Hamlin Capital Management, LLC | $177.686.548 | 1.717.608 | 0,23% | Aktien |
| Alyeska Investment Group, L.P. | $174.358.768 | 1.685.440 | 0,23% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $169.576.171 | 1.639.209 | 0,22% | Aktien |
| LPL Financial LLC | $160.912.185 | 1.555.458 | 0,21% | Aktien |
| PRUDENTIAL FINANCIAL INC | $156.319.985 | 1.511.068 | 0,20% | Aktien |
| GOLDMAN SACHS GROUP INC | $153.033.585 | 1.479.300 | 0,20% | Kaufoption |
| Quantinno Capital Management LP | $150.197.267 | 1.451.882 | 0,20% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $149.812.359 | 1.448.162 | 0,19% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $146.277.266 | 1.413.990 | 0,19% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $143.800.879 | 1.390.052 | 0,19% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $143.310.113 | 1.385.308 | 0,19% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $135.669.704 | 1.889.024 | 0,18% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $133.185.771 | 1.287.441 | 0,17% | Aktien |
| BARCLAYS PLC | $130.962.631 | 1.265.951 | 0,17% | Aktien |
| UBS Group AG | $130.742.593 | 1.263.824 | 0,17% | Aktien |
| MACQUARIE GROUP LTD | $130.222.860 | 1.258.800 | 0,17% | Aktien |
| Patient Capital Management, LLC | $127.813.106 | 1.235.505 | 0,17% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $125.407.000 | 1.212.248 | 0,16% | Aktien |
| Maple Rock Capital Partners Inc. | $123.932.686 | 1.197.996 | 0,16% | Aktien |
| BANK OF MONTREAL /CAN/ | $120.915.774 | 1.168.833 | 0,16% | Aktien |
| Qube Research & Technologies Ltd | $118.745.083 | 1.147.850 | 0,15% | Aktien |
| TD Asset Management Inc | $117.174.298 | 1.132.666 | 0,15% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $114.781.970 | 1.108.148 | 0,15% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $114.360.975 | 1.105.471 | 0,15% | Aktien |
| AVIVA PLC | $113.872.588 | 1.100.750 | 0,15% | Aktien |
| Integral Health Asset Management, LLC | $113.795.000 | 1.100.000 | 0,15% | Aktien |
| LETKO, BROSSEAU & ASSOCIATES INC | $113.305.164 | 1.095.265 | 0,15% | Aktien |
| TRUIST FINANCIAL CORP | $112.799.640 | 1.090.378 | 0,15% | Aktien |
| Woodline Partners LP | $112.125.214 | 1.083.859 | 0,15% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $111.580.653 | 1.078.595 | 0,14% | Aktien |
| STOREBRAND ASSET MANAGEMENT AS | $111.494.582 | 1.077.763 | 0,14% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $110.986.994 | 1.076.081 | 0,14% | Aktien |
| BANK OF NOVA SCOTIA | $103.790.874 | 1.003.295 | 0,13% | Aktien |
| Capital International, Inc./CA/ | $102.952.716 | 995.193 | 0,13% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $100.146.711 | 970.080 | 0,13% | Aktien |
| Walleye Trading LLC | $98.691.300 | 954.000 | 0,13% | Kaufoption |
| Walleye Trading LLC | $98.049.910 | 947.800 | 0,13% | Verkaufsoption |
| Korea Investment CORP | $97.590.385 | 943.358 | 0,13% | Aktien |
| JENNISON ASSOCIATES LLC | $97.539.798 | 942.869 | 0,13% | Aktien |
| SEB Asset Management AB | $96.760.081 | 935.333 | 0,13% | Aktien |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $91.910.670 | 888.455 | 0,12% | Aktien |
Unternehmensinsider 86 Insider · 48 Führungskräfte · 41 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| David J. Joyner | President, CEO and Chair | 1. April 2026 F | 70.349 | 0 | 0 | $0 |
| Karen S Lynch | President and CEO | 1. April 2024 A | 74.687 | 0 | 0 | $0 |
| Brian Newman | EVP, Chief Financial Officer | 31. Mai 2026 F | 3.008 | 0 | 0 | $0 |
| Thomas F. Cowhey | EVP and CFO | 1. April 2025 A | 41.109 | 0 | 0 | $0 |
| Shawn M Guertin | EVP & Chief Financial Officer | 1. April 2023 A | 34.706 | 0 | 0 | $0 |
| Eva C Boratto | EVP & CFO | 4. Mai 2021 S | 115.331 | 0 | 0 | $0 |
| David M Denton | EVP and CFO | 29. November 2018 S | 403 | 0 | 0 | $0 |
| David B Rickard | Chief Financial Officer | 14. Dezember 2009 M | 207.179 | 0 | 0 | $0 |
| Howard A Mclure | President, Caremark Pharm Serv | 2. November 2009 M | 0 | 0 | 0 | $0 |
| Jonathan C Roberts | EVP & Chief Operating Officer | 1. April 2022 A | 426.025 | 0 | 0 | $0 |
| James David Clark | SVP, Cont & Chief Acct Officer | 26. Juni 2026 F | 27.606 | 0 | 0 | $0 |
| Amy Compton-Phillips | EVP, Chief Medical Officer | 31. Mai 2026 F | 9.557 | 0 | 0 | $0 |
| Tilak Mandadi | EVP, Chief Exp & Tech Officer | 8. Mai 2026 S | 10.133 | 0 | 1 | $-6.230.379 |
| Prem S Shah | EVP and Group President | 31. März 2026 A | 64.356 | 0 | 0 | $0 |
| Heidi B Capozzi | EVP and Chief People Officer | 31. März 2026 A | 13.023 | 3 | 0 | $4.588 |
| Samrat S. Khichi | EVP, CPO and General Counsel | 31. März 2026 A | 33.421 | 0 | 0 | $0 |
| Steven H Nelson | EVP and President, Aetna | 31. März 2026 A | 2.900 | 1 | 0 | $1.289 |
| Sreekanth K Chaguturu | EVP and Chief Medical Officer | 1. April 2024 A | 23.666 | 0 | 0 | $0 |
| Laurie P. Havanec | EVP and Chief People Officer | 1. April 2024 A | 9.426 | 0 | 0 | $0 |
| Brian A Kane | EVP/President, Aetna | 1. April 2024 A | 12.569 | 0 | 0 | $0 |
| Finke Daniel P | EVP/Pres, Health Care Benefits | 1. April 2023 A | 35.068 | 0 | 0 | $0 |
| Michelle A Peluso | EVP and Co-President of Retail | 1. April 2023 A | 124.383 | 0 | 0 | $0 |
| Thomas M Moriarty | EVP & General Counsel | 31. Dezember 2022 F | 315.273 | 0 | 0 | $0 |
| Alan Lotvin | EVP&President-PharmacyServices | 4. August 2022 M | 109.183 | 0 | 0 | $0 |
| Troyen A Brennan | EVP and Chief Medical Officer | 3. April 2022 F | 232.676 | 0 | 0 | $0 |
| Neela Montgomery | EVP and Pres., Pharmacy/Retail | 1. April 2021 A | 29.502 | 0 | 0 | $0 |
| Lisa Bisaccia | Former EVP & Chief HR Officer | 1. April 2021 F | 66.417 | 0 | 0 | $0 |
| Joshua Matthew Flum | EVP, ENT STRATEGY & DIGITAL | 28. Februar 2021 F | 25.657 | 0 | 0 | $0 |
| Jonathan E. Mayhew | EVP - Transformation | 2. Dezember 2020 F | 6.855 | 0 | 0 | $0 |
| Derica W Rice | EVP & President, CVS Caremark | 28. Februar 2020 F | 26.827 | 0 | 0 | $0 |
| Kevin Hourican | EVP & President, CVS Pharmacy | 1. April 2019 A | 15.237 | 0 | 0 | $0 |
| Helena Foulkes | EVP & President-CVS Pharmacy | 16. Februar 2018 M | 45.107 | 0 | 0 | $0 |
| Robert O. Kraft | EVP and President - Omnicare | 3. April 2017 A | 92.360 | 0 | 0 | $0 |
| Andrew Sussman | EVP, Clinical Services | 3. April 2017 A | 16.433 | 0 | 0 | $0 |
| Stephen J Gold | EVP & CIO | 3. April 2017 A | 46.818 | 0 | 0 | $0 |
| Per Gh Lofberg | EVP | 2. Januar 2015 M | 23.419 | 0 | 0 | $0 |
| Mark Cosby | EVP & President-CVS/pharmacy | 30. September 2013 M | 45.955 | 0 | 0 | $0 |
| Laird Daniels | SVP, Cont & Chief Acct Officer | 1. April 2013 A | 17.845 | 0 | 0 | $0 |
| Douglas A Sgarro | EVP and CLO | 11. Mai 2012 M | 214 | 0 | 0 | $0 |
| Stuart M Mcguigan | SVP and CIO | 16. März 2012 M | 10.967 | 0 | 0 | $0 |
| Thomas M Ryan | Non-Executive Chairman | 3. April 2011 F | 1.156.702 | 0 | 0 | $0 |
| Sara Finley | SVP, Gen Counsel | 18. Februar 2011 F | 29.053 | 0 | 0 | $0 |
| Michael V Ferdinandi | Senior Vice President | 19. August 2009 S | 16.021 | 0 | 0 | $0 |
| Paula A Price | Controller | 12. Februar 2008 A | 16.498 | 0 | 0 | $0 |
| Edwin M Crawford | Chairman | 29. Oktober 2007 A | 135.572 | 0 | 0 | $0 |
| William R Spalding | EVP Caremark Pharmacy Services | 18. Juni 2007 M | 182 | 0 | 0 | $0 |
| Gregory S Weishar | Vice President | 3. April 2006 A | 30.161 | 0 | 0 | $0 |
| Larry D Solberg | Senior Vice President | 16. Februar 2006 A | 5.978 | 0 | 0 | $0 |
| ROBBINS LARRY | Direktor | 21. Mai 2026 S | 4.824.799 | 0 | 8 | $-352.750.556 |
| Fernando Aguirre | Direktor | 21. Mai 2026 D | 10.513 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| CVS Caremark Corporation | 7. Januar 2011 | — | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 218 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHF · iShares Trust | 13,66% | 1.756.753 SH | 8. August 2026 | Täglich |
| ROPE · EA Series Trust | 5,27% | 4.922 NS | 29. Mai 2026 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 4,57% | 636.042 NS | 30. April 2026 | N-PORT |
| IYK · iShares Trust | 4,22% | 624.816 SH | 8. August 2026 | Täglich |
| GEND · Spinnaker ETF Series | 3,66% | 1.968 NS | 30. April 2026 | N-PORT |
| PEZ · Invesco Exchange-Traded Fund Trust | 3,42% | 8.210 SH | 8. August 2026 | Täglich |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 2,71% | 3.618 NS | 30. April 2026 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2,58% | 79.142 NS | 31. Mai 2026 | N-PORT |
| DWLD · Davis Fundamental ETF Trust | 2,33% | 158.312 NS | 30. April 2026 | N-PORT |
| SDOG · ALPS ETF Trust | 2,25% | 342.879 NS | 31. Mai 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 2,16% | 4.706.232 NS | 30. April 2026 | N-PORT |
| QQWZ · Pacer Funds Trust | 2,15% | 12.078 NS | 30. April 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,95% | 2.024.890 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 1,94% | 3.824.297 SH | 8. August 2026 | Täglich |
| FXG · First Trust Exchange-Traded AlphaDE… | 1,89% | 55.579 NS | 30. April 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 1,88% | 334.242 SH | 8. August 2026 | Täglich |
| SPDV · ETF Series Solutions | 1,86% | 20.100 NS | 30. April 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 1,71% | 585.200 NS | 30. April 2026 | N-PORT |
| RXL · ProShares Trust | 1,67% | 13.266 NS | 31. Mai 2026 | N-PORT |
| IXJ · iShares Trust | 1,55% | 670.400 SH | 8. August 2026 | Täglich |
| REVS · Columbia ETF Trust I | 1,55% | 52.621 NS | 30. April 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 1,53% | 25.368 NS | 30. April 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,48% | 120.955 SH | 8. August 2026 | Täglich |
| SPVM · Invesco Exchange-Traded Fund Trust | 1,45% | 19.889 SH | 8. August 2026 | Täglich |
| PWV · Invesco Exchange-Traded Fund Trust | 1,40% | 261.212 SH | 8. August 2026 | Täglich |
| VLUE · iShares Trust | 1,38% | 1.353.743 SH | 8. August 2026 | Täglich |
| DVY · iShares Trust | 1,37% | 3.341.969 SH | 8. August 2026 | Täglich |
| ITAN · EA Series Trust | 1,36% | 13.295 NS | 29. Mai 2026 | N-PORT |
| GKAT · Advisors Series Trust | 1,30% | 27.039 NS | 31. März 2026 | N-PORT |
| GMOV · GMO ETF Trust | 1,21% | 12.118 NS | 31. Mai 2026 | N-PORT |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 1,17% | 41.394.000 | 8. August 2026 | Täglich |
| GURU · Global X Funds | 1,17% | 8.187 NS | 30. April 2026 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 1,13% | 16.706 NS | 31. Mai 2026 | N-PORT |
| SPXD · DBX ETF Trust | 1,12% | 830 NS | 31. Mai 2026 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 1,11% | 31.567.000 | 8. August 2026 | Täglich |
| CVAR · ETF Opportunities Trust | 1,01% | 4.716 NS | 30. April 2026 | N-PORT |
| VCEB · VANGUARD WORLD FUND | 0,99% | 12.250.700 PA | 8. August 2026 | Täglich |
| CGCV · Capital Group Conservative Equity E… | 0,99% | 189.872 NS | 31. Mai 2026 | N-PORT |
| PALC · Pacer Funds Trust | 0,98% | 27.132 NS | 30. April 2026 | N-PORT |
| ABCS · EA Series Trust | 0,98% | 1.219 NS | 29. Mai 2026 | N-PORT |
| FFLV · FIDELITY COVINGTON TRUST | 0,97% | 2.025 NS | 30. April 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,95% | 77.895 SH | 8. August 2026 | Täglich |
| EQWL · Invesco Exchange-Traded Fund Trust | 0,92% | 267.202 SH | 8. August 2026 | Täglich |
| FNDX · SCHWAB STRATEGIC TRUST | 0,91% | 2.553.383 NS | 31. Mai 2026 | N-PORT |
| VCLT · VANGUARD SCOTTSDALE FUNDS | 0,91% | 98.192.000 PA | 8. August 2026 | Täglich |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,88% | 87.427 SH | 8. August 2026 | Täglich |
| AKAF · ETF Series Solutions | 0,84% | 271 NS | 31. Mai 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,83% | 120.850 NS | 31. Mai 2026 | N-PORT |
| RECS · Columbia ETF Trust I | 0,81% | 529.096 NS | 30. April 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,81% | 10.773 NS | 30. April 2026 | N-PORT |